Client Background
This case study presents a Canada-based medical device legal and actual manufacturer engaged in the production of orthopaedic trauma implants, specifically trauma plates and screws used in fracture fixation procedures. The product portfolio included multiple models and sizes designed for various anatomical applications.
As per the Indian Medical Device Rules, 2017, these devices were classified under Class C, indicating moderate-to-high risk, thereby requiring a detailed regulatory review and approval process by the Central Drugs Standard Control Organization (CDSCO).
The client’s objective was to obtain an Import License – Form MD-15 to enable legal importation, marketing, and distribution of their orthopaedic implants within the Indian market.
Project Objective
- To secure CDSCO Import License MD-15 for Class C orthopaedic implants
- To ensure full compliance with Indian Medical Device Rules, 2017
- To align global documentation with CDSCO regulatory expectations
- To address gaps in technical documentation, certification, and labelling
- To manage end-to-end submission via the CDSCO Online System for Medical device portal
Key Regulatory Challenges Faced
The project involved multiple critical challenges requiring both regulatory expertise and technical intervention:
1.Regulatory Non-Compliance with Indian MDR 2017
- Existing documentation was primarily aligned with international standards but lacked full compliance with Indian regulatory requirements.
- Several elements required restructuring to meet CDSCO expectations.
2.Incomplete and Outdated Technical Documentation
- Updated test reports and validation documents for certain product models were unavailable.
- Inconsistencies in technical data across different product variants.
3.Free Sale Certificate (FSC) Discrepancies
- Product models listed in the FSC did not fully match the intended submission scope.
- Required alignment between regulatory certificates and product listings.
4.Labelling Non-Conformities
- Labels did not meet as per following regulatory standard and IMDR Rule 2017
- ISO 15223-1:2021 Medical devices – Symbol to be used with Information to be supplied by the manufacturer – Part 1: General Requirements
- Chapter VI – Labelling of Medical Devices – Rule 44 of Indian Medical Device Rule 2017
5.Device Master File (DMF) Gaps
- Missing or insufficient information in key sections:
- Device description and specifications
- Material composition
- Sterilization and shelf-life validation
- Biocompatibility and performance data
6.Query Management Complexity
- CDSCO raised multiple queries requiring precise technical justifications and document revisions within strict timelines.
Medfins International’s Strategy and Implementation:
Medfins International acted as an Indian Authorised Agent provided end-to-end support and expertise in regulatory compliance, Import License MD – 15
Solutions Implemented by Medfins International
Medfins International address the identified regulatory and technical challenges executed a structured, compliant, and strategic approach as outlined below:
1.Regulatory Compliance Alignment
- Performed a detailed clause-by-clause mapping of existing documentation against Indian Medical Device Rules, 2017.
- Classified the instruments appropriately as non-sterile and non-measuring and registered separately.
- Segregated product families such as femur and tibia systems along with their respective components for clarity in submission.
- Re-structured technical and regulatory documents to align with CDSCO expectations and Indian submission formats.
- Identified and selected appropriate predicate devices for substantial equivalence comparison
- Developed India-specific regulatory documentation, including Essential Principles Checklist and compliance declarations.
2.Technical Documentation Remediation
- Coordinated with the manufacturer to obtain updated test reports, validation data, and performance studies.
- Standardized technical documentation across all product models to ensure consistency.
- Compiled missing data through structured documentation, technical justifications, and bridging rationale where applicable.
3.Free Sale Certificate (FSC) Alignment
- Conducted a detailed comparison between models in FSC-listed and models requested by the manufacturer.
- Identified mismatches and coordinated with the manufacturer for revised FSC or supporting declarations.
- Ensured complete alignment between FSC, Device Master File, and submission scope to avoid regulatory objections.
4.Device Master File Development
- Developed a comprehensive Device Master as per Part III Appendix II of IMDR 2017 including:
- Executive Summary
- Detailed device description and specifications
- Predicate Comparison Report
- Essential Principles Checklist
- Biocompatibility data aligned with ISO 10993: 2018
- Prepared risk management documentation in line with ISO 14971: 2019 standard
- Ensured technical completeness and provided scientific justification across the required sections.
5.Plant Master File (PMF) Compilation
- Prepared PMF as per Part III Appendix I of IMDR 2017 including :
- Manufacturing facility details including the site layout
- Aligned details of manufacturer ISO 13485:2016 Quality Management System
- List of Qualified Personnels
- Process flow and controls
- Cleanroom and environmental controls
- Equipment and validation status
- Contract Activities
6.Regulatory Documentation Review
- Reviewed and validated:
- ISO 13485:2016 certificate
- Marketing Authorisation of Canada
- Plant Registration
- Latest Audit report
- Resolved discrepancies in Free Sale Certificate:
- Ensured alignment of product models with submission scope
- Coordinated with manufacturer for updated documentation
7.Labelling Compliance
- Coordinated with manufacturer for redesigning product labels in compliance with:
- Rule 44 – Chapter VI of Indian Medical Device Rules, 2017
- ISO 15223-1:2021 requirements
- Incorporated mandatory elements as per the Rule 44 of IMDR and ISO 15223-1:2021 such as:
- Name of the device
- Legal and actual manufacturer name and address
- Model number along with the applicable symbol
- Batch/Lot number for traceability
- Symbols for “Non-sterile” and “Do not reuse”
- Implant card provisions, including:
- Patient name
- Patient identification number
- Date of surgery
- Appropriate symbols with designated space for implementation
- Verified label accuracy and consistency across all product variants.
8.Import license Application Submission
- Prepared and submitted the complete application via CDSCO Online System for Medical Device portal:
- Form MD-14 (application)
- Supporting technical documentation
- Regulatory certificates
- Ensured accuracy and completeness to avoid rejection or delays.
9.CDSCO Query Handling
- Managed multiple rounds of queries effectively:
- Provided detailed technical justifications
- Submitted revised documents within timelines
- Coordinated closely with manufacturer for prompt responses
10.End-to-End Regulatory Management
- Managed all regulatory interactions, submissions, and follow-ups.
- Provided continuous regulatory guidance to the manufacturer throughout the lifecycle of the MD – 15 process.
Outcome
- Import License (MD-15) successfully granted
- Multiple orthopaedic implant models along with the components approved for Indian market
- All CDSCO queries addressed successfully
- Achieved full compliance with Medical Device Rules, 2017
- Enabled smooth market entry for the client in India
Key Value Delivered
- Reduced regulatory delays through structured submission
- Strengthened technical documentation to global and Indian standards
- Ensured long-term compliance readiness for audits and renewals
- Provided complete regulatory confidence for market expansion
Summary of Medfins’ Impact
- Successfully converted non-compliant and incomplete documentation into a fully CDSCO-compliant dossier
- Eliminated regulatory gaps through structured and strategic intervention
- Reduced risk of rejection and ensured smooth approval process
- Enabled successful grant of MD-15 Import License within regulatory framework
Conclusion
This project demonstrates strong expertise in handling complex CDSCO import licensing for Class C medical devices, particularly orthopaedic implants. By addressing critical documentation gaps, aligning international certifications with Indian requirements, and managing end-to-end regulatory processes, the project achieved successful approval within an efficient timeline.
The case reflects a deep understanding of CDSCO expectations, making it a strong example of effective regulatory strategy and execution in the Indian medical device landscape.